Cytokine Receptors in the Brain

NeuroImmune Biology

Volumn 6, Issue C, 2008, Pages

  Conti, Bruno ^a   Tabarean, Iustin ^a   Sanchez Alavez, Manuel ^a   Davis, Christopher ^a   Brownell, Sara ^a   Behrens, Margarita ^a   Bartfai, Tamas ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957097577     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)10002-8     Document Type: Review

References (112)

1. Ban E., Milon G., Prudhomme N., Fillion G., and Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43 1 (1991) 21-30
2. Ban EM. Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5 1 (1994) 31-40
3. Bartfai T., and Schultzberg M. Cytokines in neuronal cell types. Neurochem Int 22 5 (1993) 435-444
4. Bellinger F.P., Madamba S., and Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628 1-2 (1993) 227-234
5. Cornfield L.J., and Sills MA. High affinity interleukin-6 binding sites in bovine hypothalamus. Eur J Pharmacol 202 1 (1991) 113-115
6. Ericsson A., Liu C., Hart R.P., and Sawchenko PE. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361 4 (1995) 681-698
7. Frost P., Barrientos R.M., Makino S., Wong M.L., and Sternberg EM. IL-1 receptor type I gene expression in the amygdala of inflammatory susceptible Lewis and inflammatory resistant Fischer rats. J Neuroimmunol 121 1-2 (2001) 32-39
8. Katsuura G., Gottschall P.E., and Arimura A. Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem Biophys Res Commun 156 1 (1988) 61-67
9. Ward H., Vigues S., Poole S., and Bristow AF. The rat interleukin 10 receptor: cloning and sequencing of cDNA coding for the alpha-chain protein sequence, and demonstration by western blotting of expression in the rat brain. Cytokine 15 5 (2001) 237-240
10. Wong M.L., and Licinio J. Localization of interleukin 1 type I receptor mRNA in rat brain. Neuroimmunomodulation 1 2 (1994) 110-115
11. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., and O'Callaghan JP. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. Faseb J 20 6 (2006) 670-682
12. Ching S., He L., Lai W., and Quan N. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 19 2 (2005) 127-137
13. Lazovic J., Basu A., Lin H.W., Rothstein R.P., Krady J.K., Smith M.B., et al. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke 36 10 (2005) 2226-2231
14. Cunningham Jr. E.T., Wada E., Carter D.B., Tracey D.E., Battey J.F., and De Souza EB. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 12 3 (1992) 1101-1114
15. Gadient R.A., and Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett 153 1 (1993) 13-16
16. Zubelewicz B., Braczkowski R., Renshaw D., and Harbuz MS. Central injection of morphine stimulates plasma corticosterone and interleukin (IL)-6 and IL-6R mRNAs in the pitui tary and adrenals in adjuvant-induced arthritis. J Biol Regul Homeost Agents 13 2 (1999) 103-109
17. Hulshof S., Montagne L., De Groot C.J., and Van Der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. GLIA 38 1 (2002) 24-35
18. Ledeboer A., Breve J.J., Wierinckx A., van der Jagt S., Bristow A.F., Leysen J.E., et al. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur J Neurosci 16 7 (2002) 1175-1185
19. Mantovani A., Locati M., Vecchi A., Sozzani S., and Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22 6 (2001) 328-336
20. Andre R., Moggs J.G., Kimber I., Rothwell N.J., and Pinteaux E. Gene regulation by IL-1beta independent of IL-1R1 in the mouse brain. GLIA 53 5 (2006) 477-483
21. Grell M., Zimmermann G., Gottfried E., Chen C.M., Grunwald U., Huang D.C., et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. Embo J 18 11 (1999) 3034-3043
22. McDermott MF. TNF and TNFR biology in health and disease. Cell Mol Biol 47 4 (2001) 619-635
23. Pejovic V., Soskic V., Pan W., and Kastin AJ. Brain proteome of mice lacking the receptors for tumor necrosis factor alpha. Proteomics 4 05 (2004) 1461-1464
24. Donnelly R.P., Dickensheets H., and Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19 6 (1999) 563-573
25. Akira S. IL-6-regulated transcription factors. Int J Biochem Cell Biol 29 12 (1997) 1401-1418
26. Hibi M., Nakajima K., and Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74 1 (1996) 1-12
27. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 21 (2000) 2548-2556
28. Conti P., Kempuraj D., Frydas S., Kandere K., Boucher W., Letourneau R., et al. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett 88 3 (2003) 171-174
29. Davis C.N., Tabarean I., Gaidarova S., Behrens M.M., and Bartfai T. IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem 98 5 (2006) 1379-1389
30. Sanchez-Alavez M., Tabarean IV, Behrens M.M., and Bartfai T. Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc Natl Acad Sci USA 103 8 (2006) 2904-2908
31. Tabarean IV, Korn H., and Bartfai T. Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience 141 4 (2006) 1685-1695
32. Martin S.J., Grimwood P.D., and Morris RGM. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23 1 (2000) 649-711
33. Katsuki H., Nakai S., Hirai Y., Akaji K., Kiso Y., and Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181 3 (1990) 323-326
34. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., and O'Connor JJ. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203 1 (1996) 17-20
35. Kelly A., Lynch A., Vereker E., Nolan Y Q., Whittaker E P., et al. The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem 276 49 (2001) 45564-45572
36. Curran B., and O'Connor JJ. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108 1 (2001) 83-90
37. Ross F.M., Allan S.M., Rothwell N.J., and Verkhratsky A. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 144 1-2 (2003) 61-67
38. Avital A., Goshen I., Kamsler A., Segal M., Iverfeldt K., Richter-Levin G., et al. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13 7 (2003) 826-834
39. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176 7 (2006) 3877-3883
40. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23 25 (2003) 8692-8700
41. Gabellec M.M., Jafarian-Tehrani M., Griffais R., and Haour F. Interleukin-1 receptor accessory protein transcripts in the brain and spleen: kinetics after peripheral administration of bacterial lipopolysaccharide in mice. Neuroimmunomodulation 3 5 (1996) 304-309
42. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 97 21 (2000) 11534-11539
43. Vezzani A., Moneta D., Richichi C., Aliprandi M., Burrows S.J., Ravizza T., et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43 Suppl 5 (2002) 30-35
44. Dube C., Vezzani A., Behrens M., Bartfai T., and Baram TZ. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57 1 (2005) 152-155
45. Gatti S., Vezzani A., and Bartfai T. Putative Role of IL-1/IL-1ra in Febrile Seizures (2002), Academic Press, San Diego
46. Kanemoto K., Kawasaki J., Miyamoto T., Obayashi H., and Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 47 5 (2000) 571-574
47. Stepien H., Zerek-Melen G., Mucha S., Winczyk K., and Fryczak J. Interleukin-1 beta stimulates cell proliferation in the intermediate lobe of the rat pituitary gland. J Endocrinol 140 3 (1994) 337-341
48. Benigni F., Faggioni R., Sironi M., Fantuzzi G., Vandenabeele P., Takahashi N., et al. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF. J Immunol 157 12 (1996) 5563-5568
49. Dunn AJ. Cytokine activation of the HPA axis. Ann NY Acad Sci 917 (2000) 608-617
50. Bluthe R.M., Beaudu C., Kelley K.W., and Dantzer R. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res 677 1 (1995) 171-176
51. Dantzer R., Bluthe R.M., Gheusi G., Cremona S., Laye S., Parnet P., et al. Molecular basis of sickness behavior. Ann NY Acad Sci 856 (1998) 132-138
52. Ilyin S.E., Gayle D., Flynn M.C., and Plata-Salaman CR. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res Bull 45 5 (1998) 507-515
53. Bluthe R.M., Dantzer R., and Kelley KW. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 573 2 (1992) 318-320
54. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19 2 (1994) 197-207
55. Goujon E., Parnet P., Cremona S., and Dantzer R. Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice. Brain Res 702 1-2 (1995) 173-180
56. Ilyin S.E. Plata-Salaman CR. An approach to study molecular mechanisms involved in cytokine-induced anorexia. J Neurosci Methods 70 1 (1996) 33-38
57. Plata-Salaman CR. Cytokine-induced anorexia. Behavioral, cellular, and molecular mechanisms. Ann NY Acad Sci 856 (1998) 160-170
58. De Sarro G., Gareri P., Sinopoli V.A., David E., and Rotiroti D. Comparative, behavioural and electrocortical effects of tumor necrosis factor-alpha and interleukin-1 microinjected into the locus coeruleus of rat. Life Sci 60 8 (1997) 555-564
59. Bianchi M., Ferrario P., Clavenna A., and Panerai AE. Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice. Neuroreport 8 7 (1997) 1775-1778
60. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58 5 (2001) 445-452
61. Lynch A.M., and Lynch MA. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci 15 11 (2002) 1779-1788
62. Lynch MA. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Vitam Horm 64 (2002) 185-219
63. Horai R., Saijo S., Tanioka H., Nakae S., Sudo K., Okahara A., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191 2 (2000) 313-320
64. Emsley H.C., Smith C.J., Georgiou R.F., Vail A., Hopkins S.J., Rothwell N.J., et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76 10 (2005) 1366-1372
65. Mulcahy N.J., Ross J., Rothwell N.J., and Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140 3 (2003) 471-476
66. Chai Z., Alheim K., Lundkvist J., Gatti S., and Bartfai T. Subchronic glucocorticoid pretreatment reversibly attenuates IL-beta induced fever in rats; IL-6 mRNA is elevated while IL-1 alpha and IL-1 beta mRNAs are suppressed, in the CNS. Cytokine 8 3 (1996) 227-237
67. Zetterstrom M., Lundkvist J., Malinowsky D., Eriksson G., and Bartfai T. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein. Eur Cytokine Netw 9 2 (1998) 131-138
68. Zetterstrom M., Sundgren-Andersson A.K., Ostlund P., and Bartfai T. Delineation of the proinflammatory cytokine cascade in fever induction. Ann NY Acad Sci. 856 (1998) 48-52
69. Nakashima T., Hori T., Mori T., Kuriyama K., and Mizuno K. Recombinant human interleukin-1 beta alters the activity of preoptic thermosensitive neurons in vitro. Brain Res Bull 23 3 (1989) 209-213
70. Shibata M., and Blatteis CM. Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices. Am J Physiol 261 5 Pt 2 (1991) R1096-R1103
71. Vasilenko V.Y., Petruchuk T.A., Gourine V.N., and Pierau FK. Interleukin-1beta reduces temperature sensitivity but elevates thermal thresholds in different populations of warm-sensitive hypothalamic neurons in rat brain slices. Neurosci Lett 292 3 (2000) 207-210
72. Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 31 Suppl 5 (2000) S157-S161
73. Leker R.R., and Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res - Brain Res Rev 39 1 (2002) 55-73
74. Rothwell N., Allan S., and Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100 11 (1997) 2648-2652
75. Rothwell N.J., and Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23 12 (2000) 618-625
76. Shohami E., Ginis I., and Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10 2 (1999) 119-130
77. Touzani O., Boutin H., Chuquet J., and Rothwell N. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 100 1-2 (1999) 203-215
78. Banks W.A., Plotkin S.R., and Kastin AJ. Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation 2 3 (1995) 161-165
79. Pan W., Cain C., Yu Y., and Kastin AJ. Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury. J Neuroimmunol 174 1-2 (2006) 119-125
80. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., et al. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 25 29 (2005) 6734-6744
81. Stellwagen D., Beattie E.C., Seo J.Y., and Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25 12 (2005) 3219-3228
82. Lu K.T., Wang Y.W., Wo Y.Y., and Yang YL. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett 386 1 (2005) 40-45
83. Jones N.C., Prior M.J., Burden-Teh E., Marsden C.A., Morris P.G., and Murphy S. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur J Neurosci 22 1 (2005) 72-78
84. Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T B., et al. J Neurochem 94 2 (2005) 459-468
85. Peng Y.P., Qiu Y.H., Lu J.H., and Wang JJ. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett 374 3 (2005) 192-196
86. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., et al. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma 19 8 (2002) 939-951
87. Fernandez-Real J.M., Broch M., Vendrell J., Richart C., and Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. [see comments]. J Clin Endocrinol Metab 85 3 (2000) 1334-1339
88. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 7 (1998) 1369-1376
89. Francis S.E., Camp N.J., Dewberry R.M., Gunn J., Syrris P., Carter N.D., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99 7 (1999) 861-866 [see comments]
90. Grove J., Daly A.K., Bassendine M.F., and Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26 1 (1997) 143-146 [see comments]
91. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 6 (1998) 605-612
92. Hohjoh H., Nakayama T., Ohashi J., Miyagawa T., Tanaka H., Akaza T., et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54 2 (1999) 138-145
93. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenfelde K.H., and Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 54 3 (1998) 173-177
94. Huang D., Pirskanen R., Hjelmstrom P., and Lefvert AK. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis. J Neuroimmunol 81 1-2 (1998) 76-81
95. Huang D.R., Pirskanen R., Matell G., and Lefvert AK. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis. J Neuroimmunol 94 1-2 (1999) 165-171
96. Keen R.W., Woodford-Richens K.L., Lanchbury J.S., and Spector TD. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 23 4 (1998) 367-371
97. Linker-Israeli M., Wallace D.J., Prehn J.L., Nand R., Li L., and Klinenberg JR. A greater variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity 23 3 (1996) 199-209
98. Liu Z.H., Cheng Z.H., Yu Y.S., Tang Z., and Li LS. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?. Kidney Int 51 6 (1997) 1938-1942
99. McGarry F., Walker R., Sturrock R., and Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26 5 (1999) 1110-1116
100. Morse H.R., Bidwell J.L., and Raveche ES. A poly(C) repeat polymorphism in the promoter of the IL-10 gene in NZB mice. Eur J Immunogenet 26 5 (1999) 377-378
101. Negoro K., Kinouchi Y., Hiwatashi N., Takahashi S., Takagi S., Satoh J., et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 117 5 (1999) 1062-1068
102. Roy S., McGuire W., Mascie-Taylor C.G., Saha B., Hazra S.K., Hill A.V., et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 176 2 (1997) 530-532
103. Seki N., Kamizono S., Yamada A., Higuchi T., Matsumoto H., Niiya F., et al. Polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54 2 (1999) 194-197
104. Terry C.F., Loukaci V., and Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 24 (2000) 18138-18144
105. Vinasco J., Beraun Y., Nieto A., Fraile A., Mataran L., Pareja E., et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49 1 (1997) 74-78
106. Griffin W.S., and Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukocyte Biol 72 2 (2002) 233-238
107. Tha K.K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R., et al. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res 885 1 (2000) 25-31
108. Goslin K., and Banker G. Experimental observations on the development of polarity by hippocampal neurons in culture. J Cell Biol 108 4 (1989) 1507-1516
109. Agnello D., Villa P., and Ghezzi P. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice. Brain Res 869 1-2 (2000) 241-243
110. Goujon E., Parnet P., Laye S., Combe C., and Dantzer R. Adrenalectomy enhances pro- inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res Mol Brain Res 36 1 (1996) 53-62
111. Utsuyama M., and Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp Gerontol 37 2-3 (2002) 411-420
112. Bristulf J., and Bartfai T. Interleukin-1 beta and tumour necrosis factor-alpha stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT- 20 cells. Neurosci Lett 187 1 (1995) 53-56